Related references
Note: Only part of the references are listed.Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions
Maria I. del Olmo-Garcia et al.
CANCERS (2022)
Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy
Xiangyu Deng et al.
ADVANCED SCIENCE (2021)
Somatostatin receptor radionuclide therapy in neuroendocrine tumors
Mintallah Haider et al.
ENDOCRINE-RELATED CANCER (2021)
mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
Samantha Exner et al.
FRONTIERS IN ONCOLOGY (2021)
Recent advances in selective photothermal therapy of tumor
Liping Zhao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Photothermal Therapy as Adjuvant to Surgery in an Orthotopic Mouse Model of Human Fibrosarcoma
Marina Simon et al.
CANCERS (2021)
Combination Therapies with PRRT
Anna Yordanova et al.
PHARMACEUTICALS (2021)
Targeted Cancer Therapy: What's New in the Field of Neuroendocrine Neoplasms?
Anna La Salvia et al.
CANCERS (2021)
Advances in Nanomaterial-Mediated Photothermal Cancer Therapies: Toward Clinical Applications
Hwa Seung Han et al.
BIOMEDICINES (2021)
Molecular and biological rationale of hyperthermia as radio- and chemosensitizer
A. L. Oei et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
Danny Feijtel et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
18F-FDG positron emission tomography and diffusion-weighted magnetic resonance imaging for response evaluation of nanoparticle-mediated photothermal therapy
Marina Simon et al.
SCIENTIFIC REPORTS (2020)
Enhancing the anti-tumour activity of 177Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP
Carleen Cullinane et al.
SCIENTIFIC REPORTS (2020)
Enhanced radiotherapy using photothermal therapy based on dual-sensitizer of gold nanoparticles with acid-induced aggregation
Yumin Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
Virginia Liberini et al.
DIAGNOSTICS (2020)
Combined 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option
Aadil Adnan et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2020)
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Rui-Xue Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Therapy With 177Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors
A. Tuba Kendi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Fractionated photothermal therapy in a murine tumor model: comparison with single dose
Marina Simon et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
Ardeshir R. Rastinehad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment
Zuhong Li et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
Ute Hennrich et al.
PHARMACEUTICALS (2019)
Neuroendocrine Tumor Therapy: Lu-177-DOTATATE
Erik S. Mittra
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Doxorubicin/gold nanoparticles coated with liposomes for chemo-photothermal synergetic antitumor therapy
Shanshan Xing et al.
NANOTECHNOLOGY (2018)
Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer
Jutaek Nam et al.
NATURE COMMUNICATIONS (2018)
The combined therapeutic effects of 131iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer
Qiufang Liu et al.
ACTA PHARMACEUTICA SINICA B (2018)
Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
Keunyoung Kim et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Adjuvant Photothermal Therapy Inhibits Local Recurrences after Breast-Conserving Surgery with Little Skin Damage
Shouju Wang et al.
ACS NANO (2018)
Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
Tiago Nunes da Silva et al.
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2018)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
18F-FDG PET/CT-based early treatment response evaluation of nanoparticle-assisted photothermal cancer therapy
Kamilla Norregaard et al.
PLOS ONE (2017)
Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials
Duarte de Melo-Diogo et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?
Jan C. Peeken et al.
FRONTIERS IN ONCOLOGY (2017)
Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer
Simmyung Yook et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Towards Effective Photothermal/Photodynamic Treatment Using Plasmonic Gold Nanoparticles
Alla Bucharskaya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Radionuclide 131I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer
Lei Chen et al.
BIOMATERIALS (2015)
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
Tamer Refaat et al.
BREAST (2015)
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies
Sander M. Bison et al.
EJNMMI RESEARCH (2015)
Nanoparticles for photothermal therapies
D. Jaque et al.
NANOSCALE (2014)
Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments
Sander M. Bison et al.
CLINICAL AND TRANSLATIONAL IMAGING (2014)
Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing Lu-177-DOTA-Octreotate Treatment
Mattias Sandstrom et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
Andreas Pfeifer et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi
Christof Seidl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
SSTR2-Based Reporters for Assessing Gene Transfer into Non-Small Cell Lung Cancer: Evaluation Using an Intrathoracic Mouse Model
S. P. Singh et al.
HUMAN GENE THERAPY (2011)
Nanoshell-mediated photothermal therapy improves survival in a murine glioma model
Emily S. Day et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Combined Hyperthermia and Radiotherapy for the Treatment of Cancer
Punit Kaur et al.
Cancers (2011)
Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
Dik J. Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hyperthermia: a potent enhancer of radiotherapy
M. R. Horsman et al.
CLINICAL ONCOLOGY (2007)
Production logistics of 177Lu for radionuclide therapy
MRA Pillai et al.
APPLIED RADIATION AND ISOTOPES (2003)
Share Paper
